Paper24319201
Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.
Verneris MR. Hematology Am Soc Hematol Educ Program, 2013. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL. Papers, record 24319201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24319201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Communication | Major topic |
| Graft vs Leukemia Effect | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Killer Cells, Natural | Major topic |
| Self Tolerance | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Allografts | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI100879 | NIAID NIH HHS | United States | R01AI100879 | PubMed and NIH |
Source NIH RePORTER
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20952687 | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. | Blood | 2011 | https://conductscience.org/library/papers/20952687 | PubMed |
| 2 | 16230475 | CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. | J Exp Med | 2005 | https://conductscience.org/library/papers/16230475 | PubMed |
| 3 | 23085463 | Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study. | Exp Hematol | 2013 | https://conductscience.org/library/papers/23085463 | PubMed |
| 4 | 21593401 | Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. | Sci Transl Med | 2011 | https://conductscience.org/library/papers/21593401 | PubMed |
| 5 | 19464988 | Human T regulatory cell therapy: take a billion or so and call me in the morning. | Immunity | 2009 | https://conductscience.org/library/papers/19464988 | PubMed |
| 6 | 19308771 | Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. | Cytotherapy | 2009 | https://conductscience.org/library/papers/19308771 | PubMed |
| 7 | 17309822 | Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. | Exp Hematol | 2007 | https://conductscience.org/library/papers/17309822 | PubMed |
| 8 | 17555453 | Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants. | Br J Haematol | 2007 | https://conductscience.org/library/papers/17555453 | PubMed |
| 9 | 20233969 | NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. | Blood | 2010 | https://conductscience.org/library/papers/20233969 | PubMed |
| 10 | 19536194 | Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. | Nat Immunol | 2009 | https://conductscience.org/library/papers/19536194 | PubMed |
| 11 | 18209070 | NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. | J Immunol | 2008 | https://conductscience.org/library/papers/18209070 | PubMed |
| 12 | 17504991 | The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17504991 | PubMed |
| 13 | 21802270 | Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. | Curr Opin Immunol | 2011 | https://conductscience.org/library/papers/21802270 | PubMed |
| 14 | 16902150 | Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. | Blood | 2006 | https://conductscience.org/library/papers/16902150 | PubMed |
| 15 | 22279576 | Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22279576 | PubMed |
| 16 | 21905023 | Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells. | Eur J Immunol | 2011 | https://conductscience.org/library/papers/21905023 | PubMed |
| 17 | 17100876 | Human natural killer cell development. | Immunol Rev | 2006 | https://conductscience.org/library/papers/17100876 | PubMed |
| 18 | 19009291 | The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells. | Cancer Immunol Immunother | 2009 | https://conductscience.org/library/papers/19009291 | PubMed |
| 19 | 2543925 | Severe herpesvirus infections in an adolescent without natural killer cells. | N Engl J Med | 1989 | https://conductscience.org/library/papers/2543925 | PubMed |
| 20 | 20581313 | Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. | Blood | 2010 | https://conductscience.org/library/papers/20581313 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957925 | TRAIL orchestrates ThINKK-induced NK cell cytotoxicity against childhood acute lymphoblastic leukemia. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42957925 | PubMed |
| 41550465 | Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41550465 | PubMed |
| 38500877 | Metabolic instruction of the graft-versus-leukemia immunity. | Front Immunol | 2024 | https://conductscience.org/library/papers/38500877 | PubMed |
| 38495918 | Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice. | Clin Transl Immunology | 2024 | https://conductscience.org/library/papers/38495918 | PubMed |
| 31281532 | Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers. | Theranostics | 2019 | https://conductscience.org/library/papers/31281532 | PubMed |
| 30632032 | Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells. | Cytotechnology | 2019 | https://conductscience.org/library/papers/30632032 | PubMed |
| 29907809 | Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide. | Leukemia | 2019 | https://conductscience.org/library/papers/29907809 | PubMed |
| 29868032 | Advance in Targeted Immunotherapy for Graft-Versus-Host Disease. | Front Immunol | 2018 | https://conductscience.org/library/papers/29868032 | PubMed |
| 29380244 | Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture. | Mol Cell Biochem | 2018 | https://conductscience.org/library/papers/29380244 | PubMed |
| 29350342 | Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation. | J Cell Commun Signal | 2018 | https://conductscience.org/library/papers/29350342 | PubMed |
| 28644756 | Immunological effects of hypomethylating agents. | Expert Rev Hematol | 2017 | https://conductscience.org/library/papers/28644756 | PubMed |
| 28194759 | Association of peripheral NK cell counts with Helios+ IFN-γ- Tregs in patients with good long-term renal allograft function. | Clin Exp Immunol | 2017 | https://conductscience.org/library/papers/28194759 | PubMed |
| 28123892 | Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/28123892 | PubMed |
| 27809910 | Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. | J Biomed Sci | 2016 | https://conductscience.org/library/papers/27809910 | PubMed |
| 27094002 | [Progress on allogeneic hematopoietic stem cell transplantation in peripheral T cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2016 | https://conductscience.org/library/papers/27094002 | PubMed |
| 26588681 | Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer. | Cancer J | 2015 | https://conductscience.org/library/papers/26588681 | PubMed |
| 26552660 | The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch. | Immunogenetics | 2016 | https://conductscience.org/library/papers/26552660 | PubMed |
| 25549354 | CCR7 expressing mesenchymal stem cells potently inhibit graft-versus-host disease by spoiling the fourth supplemental Billingham's tenet. | PLoS One | 2014 | https://conductscience.org/library/papers/25549354 | PubMed |
Genes58
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24319201
GET https://conductscience.org/api/papers/v1/24319201/references?page=2